Virpax Pharmaceuticals, Inc. (VRPX)

NASDAQ: VRPX · IEX Real-Time Price · USD

2.540

-0.170 (-6.27%)

At close: May 1, 2024, 4:00 PM

2.502

-0.038 (-1.50%)

After-hours: May 1, 2024, 6:57 PM EDT

Virpax Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	3	4	7	40	-	-	-
Market Cap Growth	-	-48.56%	-81.86%	-	-	-	-
Enterprise Value	-6	-5	-12	3	2	1	0
PE Ratio	-0.25	-0.25	-0.34	-3.33	-	-	-
PB Ratio	1.54	1.94	0.44	1.07	-	-	-
P/FCF Ratio	-0.38	-0.38	-0.41	-2.76	-	-	-
P/OCF Ratio	-0.38	-0.38	-0.41	-2.76	-	-	-
EV/EBITDA Ratio	0.35	0.35	0.54	-0.28	-0.36	-0.38	-0.17
EV/EBIT Ratio	0.35	0.35	0.54	-0.28	-0.36	-0.38	-0.17
EV/FCF Ratio	0.55	0.55	0.66	-0.23	-1.09	-1.08	-0.25
Debt / Equity Ratio	-	-	-	-	-0.37	-0.46	-0.42
Debt / EBITDA Ratio	-	-	-	-	-0.37	-0.40	-0.19
Debt / FCF Ratio	-	-	-	-	-1.13	-1.12	-0.28
Quick Ratio	1.19	1.19	6.14	17.65	0.01	0.01	0.04
Current Ratio	1.25	1.25	6.36	18.95	0.02	0.02	0.05
Interest Coverage	-	-	-	-128.88	-28.34	-25.53	-175.34
Return on Equity (ROE)	-169.00%	-169.00%	-90.70%	-50.20%	124.90%	168.50%	-
Return on Assets (ROA)	-106.40%	-106.40%	-80.60%	-44.90%	-1694.80%	-6110.80%	-
Return on Capital (ROIC)	-811.13%	-811.13%	-131.76%	-32.08%	158.30%	216.78%	379.08%
Earnings Yield	-510.58%	-405.08%	-297.00%	-30.00%	-	-	-
FCF Yield	-331.23%	-262.78%	-244.81%	-36.19%	-	-	-
Buyback Yield / Dilution	-0.02%	-0.02%	-75.37%	-114.88%	-6.09%	-3.18%	-
Total Shareholder Return	-0.02%	-0.02%	-75.37%	-114.88%	-6.09%	-3.18%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).